Change of name to Realm Therapeutics

PuriCore plc

("PuriCore" or the "Company")

PuriCore announces change of name to Realm Therapeutics

Shares to trade under RLM ticker from tomorrow

7 December 2016 - PuriCore plc (AIM: PURI), an emerging specialty biopharmaceutical company focused on leveraging its proprietary immunomodulatory technology, is pleased to announce that, further to an announcement made on 16 November 2016, the Company expects to complete its change of name today from PuriCore plc to Realm Therapeutics plc to more accurately reflect the Company's strategic focus and direction.

It is expected that with effect from 8:00am on 8 December 2016 the Company's shares will trade under its new name of Realm Therapeutics plc and the Company's London Stock Exchange Tradable Instrument Display Mnemonic ("TIDM") will change to RLM. The Company's ISIN number will remain unchanged. The Company's website address will be www.realmtx.com.

Enquiries:

About PuriCore

PuriCore is an emerging specialty biopharmaceutical company focused on developing novel immunomodulatory therapies to protect and improve the lives of adults and children. The Company has initiated drug development programmes, based on its proprietary hypochlorous acid technology at high concentrations. The Company believes their formulations have novel immunomodulatory activity with potential application for the treatment of diseases in a number of therapeutic areas including Dermatology and Ophthalmology.

Forward looking statements

Certain statements made in this announcement are forward-looking statements. These forward-looking statements are not historical facts but rather are based on the Company's current expectations, estimates, and projections about its industry; its beliefs; and assumptions. Words such as 'anticipates,' 'expects,' 'intends,' 'plans,' 'believes,' 'seeks,' 'estimates,' and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties, and other factors, some of which are beyond the Company's control, are difficult to predict, and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. The Company cautions shareholders and prospective shareholders not to place undue reliance on these forward-looking statements, which reflect the view of the Company only as of the date of this announcement. The forward-looking statements made in this announcement relate only to events as of the date on which the statements are made. The Company will not undertake any obligation to release publicly any revisions or updates to these forward-looking statements to reflect events, circumstances, or unanticipated events occurring after the date of this announcement except as required by law or by any appropriate regulatory authority.